There is value in simply obtaining intellectual property (IP) rights. However, as our President, Mr. Miyazaki, expressed in our corporate vision elsewhere on our website, IP rights are also a valuable asset. Our role thus does not end once we have helped you secure your IP rights. More and more, Japanese clients are seeking to create additional value from their IP assets through licensing and litigation, and NGB is right there with them. Whether you are negotiating a license in India or China, opposing an IP rights grant in the European Union, or involved in a hotly-contested litigation in the United States, NGB has been there before, and has the experience and strong working relationships to help you meet your goals. As in the prosecution arena, we draw on our global network of premiere law firms and the lessons we have learned over the years to help you leverage your IP rights and transform them into value-creating IP assets.
NGB has broad litigation and negotiation support experience. For example, we have helped clients in obtaining and managing validity and infringement opinions, planning enforcement strategies, evaluating patent portfolios, and discussing the latest patent law changes in countries throughout the world and what these changes mean to your business. In addition, we routinely help our clients to navigate through various controversies in the U.S. Federal and Appellate Courts, the European Courts, and the Chinese Courts, and in actions associated with the U.S. Food and Drug Administration (FDA) Abbreviated New Drug Application (ANDA) process. Whatever your particular challenge, NGB has the experience, understanding, and resources to help you through it.